The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Tirzepatide is approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with ... reductions in breathing disruptions and weight loss with tirzepatide. Nearly half of trial ...

The regulator approved the drug for moderate to severe obstructive sleep apnea ... weight-loss treatments, though the Biden administration has proposed to expand the coverage of anti-obesity drugs.

Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Future of Healthcategory ... blockbuster weight loss and diabetes drugs following a re-evaluation of ...